EP Patent

EP2455075B1 — Process for Preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine

Assigned to Sumitomo Pharma America Inc · Expires 2018-06-20 · 8y expired

What this patent protects

Patent listed against edoxaban-tosylate.

Drugs covered by this patent

Patent Metadata

Patent number
EP2455075B1
Jurisdiction
EP
Classification
—
Expires
2018-06-20
Drug substance claim
No
Drug product claim
No
Assignee
Sumitomo Pharma America Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.